INCIDENCE OF PRIMARY CARDIOVASCULAR RISK FACTORS  IN PATIENTS WITH ERECTILE DYSFUNCTION

I. DUMBRAVEANU; T. BRANISHTE; P. BANOV; I. ARIAN; B. BALUTEL; E. CEBAN

I. DUMBRAVEANU State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau
T. BRANISHTE State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau
P. BANOV State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau
I. ARIAN State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau
B. BALUTEL “Timoftei Mosneaga” Republic Hospital-Chisinau, Urology Clinic
E. CEBAN State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Abstract

Aim: Identification of primary cardiovascular risk factors in patients with erectile dysfunction. Material and methods: The study included 308 apparently healthy men, with a mean age of 45±12.1 years. The Sexual Health Inventory for Men (SHIM) questionnaire was used to determine the following indices: BMI, blood pressure, blood glucose, cholesterol, triglycerides, etc. Results: The total incidence of cardiovascular risk factors was 56%: 45% in men aged up to 40 years (group I) and 74% in those over 40 years (group II). High blood pressure was found in 9% of the men in group I and 55% in those in group II (p <0.05). Blood glucose levels were recorded in 5% of group I patients 24% in group II patients. Sixty-six percent of the men over 40 years were overweight compared with 16% of men under age 40. Dyslipidemia was present in 65% of group I versus 19% in group II. Conclusions: Our study shows that especially in men over 40 years of age erectile dysfunction is a vascular endothelial condition clearly associated with cardiovascular risk factors; the direct association between the severity of erectile dysfunction and increased levels of cardiovascular risk factors reflects their importance in the occurrence and course of the disease, which should be taken into account when diagnosing an erectile dysfunction and selecting the therapeutic approach.

Author Biographies

I. DUMBRAVEANU, State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Faculty of Medicine
Department of Surgical Urology and Nephrology

T. BRANISHTE, State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Faculty of Medicine
Clinic of Medical Semiology

P. BANOV, State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Faculty of Medicine
Department of Surgical Urology and Nephrology

I. ARIAN, State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Faculty of Medicine
Department of Surgical Urology and Nephrology

E. CEBAN, State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau

Faculty of Medicine
Department of Surgical Urology and Nephrology

References

1. Roth G.A, Forouzanfar M.H, Moran A.E. et al. Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality. N. Engl. J. Med. 2015; 372: 1333-1341.
2. Wespes E., Eardley I., Giuliano F. et al. Guidelines on Male Sexual Dysfunction: Erectile dysfunction and premature ejaculation. European Association of Urology. Amsterdam. 2013; http://uroweb.org/wp-content/uploads/14_Male-Sexual Dysfunction_LR.pdf. Accessed: 04.12.2017.
3. Feldman H.A, Goldstein I., Hatzichristou D.G. et al. Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study, J. Urol. 1994; 151(1): 54-61.
4. Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int. J. Impot. Res. 2000; 12: 305-311.
5. Doumas M., Tsakiris A., Douma Stella, et al. Factors Affecting the Increased Prevalence of Erectile Dysfunction in Greek Hypertensive Compared With Normotensive Subjects. J. Androl. 2006; 27 (3): 469-477.
6. Hodges L.D, Kirby M., Solanki J., O'Donnell J. & Brodie D.A. The temporal relationship between erectile dysfunction and cardiovascular disease. Internat. J. Clin. Pract. 2007; 61: 2019–2025.
7. Montorsi P., Montorsi F., Schulman C.C. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur. Urol 2003; 44(3): 352–354.
8. Gandaglia G., Briganti A., Jackson G. et al. A Systematic Review of the Association Between Erectile Dysfunction and Cardiovascular Disease. Europ. Urol 2014; 65(5): 968-978.
9. Standards of Medical Care in Diabetes. American Diabetes Association. Diabetes Care 2011; 34: 4-10.
10. Caproş N., Barbacar N., Istrati V., Branişte T. Aspects of the molecular-genetic profile in patients with ischemic heart disease. Rev. Med. Chir. Soc. Med. Nat. Iasi 2013; 117(1): 78-82.
11. Branishte T., Braniște A. Coronary circulation and cardiac hemodynamics – morpho functional and immunohistochemical particularities in patients with ischemic heart disease. Rev. Med. Chir. Soc. Med. Nat. Iasi 2017; 121(1): 41-45.
12. Montrosi P., Ravaghani P., Galli S. et al. Association between erectile dysfunction and coronary artery dissease. Role of coronary clinical presentation and extent of coronary vessels involvement. The COBRA trial. Eur. Heart. J 2006; 27(22): 2632-2639.
13. Nehra A., Jacson G., Miner M. et al. The Princeton III Consensus recommendations for the manage-ment of erectile dysfunction and cardiovascular disease. Mayo. Clinic. Proc. 2012; 87: 766-778.
14. Catapano AL, Graham I, De Backer G. et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Europ. Heart J 2016; 37 (39): 2999 – 3058.
15. Dahabreh I, Paulus J. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA 2011; 305(12): 1225-1233.